1. Home
  2. MTEK vs APLM Comparison

MTEK vs APLM Comparison

Compare MTEK & APLM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MTEK
  • APLM
  • Stock Information
  • Founded
  • MTEK 2008
  • APLM 2016
  • Country
  • MTEK Israel
  • APLM United States
  • Employees
  • MTEK N/A
  • APLM N/A
  • Industry
  • MTEK
  • APLM Blank Checks
  • Sector
  • MTEK
  • APLM Finance
  • Exchange
  • MTEK Nasdaq
  • APLM Nasdaq
  • Market Cap
  • MTEK 14.7M
  • APLM 15.6M
  • IPO Year
  • MTEK 2022
  • APLM N/A
  • Fundamental
  • Price
  • MTEK $2.07
  • APLM $0.13
  • Analyst Decision
  • MTEK
  • APLM Strong Buy
  • Analyst Count
  • MTEK 0
  • APLM 2
  • Target Price
  • MTEK N/A
  • APLM $4.25
  • AVG Volume (30 Days)
  • MTEK 25.1K
  • APLM 872.1K
  • Earning Date
  • MTEK 10-22-2024
  • APLM 08-14-2024
  • Dividend Yield
  • MTEK N/A
  • APLM N/A
  • EPS Growth
  • MTEK N/A
  • APLM N/A
  • EPS
  • MTEK N/A
  • APLM N/A
  • Revenue
  • MTEK $6,967,508.00
  • APLM $2,101,000.00
  • Revenue This Year
  • MTEK N/A
  • APLM N/A
  • Revenue Next Year
  • MTEK N/A
  • APLM N/A
  • P/E Ratio
  • MTEK N/A
  • APLM N/A
  • Revenue Growth
  • MTEK 246.50
  • APLM 70.54
  • 52 Week Low
  • MTEK $0.94
  • APLM $0.11
  • 52 Week High
  • MTEK $2.07
  • APLM $2.15
  • Technical
  • Relative Strength Index (RSI)
  • MTEK 64.45
  • APLM 44.84
  • Support Level
  • MTEK $1.80
  • APLM $0.13
  • Resistance Level
  • MTEK $2.06
  • APLM $0.17
  • Average True Range (ATR)
  • MTEK 0.11
  • APLM 0.01
  • MACD
  • MTEK 0.02
  • APLM -0.00
  • Stochastic Oscillator
  • MTEK 92.74
  • APLM 24.14

About MTEK Maris-Tech Ltd.

Maris Tech Ltd is a provider of remote video, audio, telemetry acquisition, distribution, and sharing solutions and products, using high-end digital video, audio, and wireless communication technologies. It designs, develops, manufactures and commercially sells miniature intelligent video and audio surveillance and communication systems, which are offered as products and solutions for the professional as well as the civilian and home security markets.

About APLM Apollomics Inc.

Apollomics Inc is an innovative clinical-stage biopharmaceutical company focused on the discovery and development of oncology therapies with the potential to be combined with other treatment options to harness the immune system and target specific molecular pathways to inhibit cancer. The company lead programs include vebreltinib (APL-101), a potent, selective c-Met inhibitor for the treatment of non-small cell lung cancer and other advanced tumors with c-Met alterations, and uproleselan (APL-106), a specific E-Selectin antagonist that has the potential to be used adjunctively with standard chemotherapy to treat acute myeloid leukemia.

Share on Social Networks: